Procter & Gamble Health Ltd.
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company is almost debt free
- Latest quarter profit grew 45.3% YoY, showing strong momentum
- Working capital cycle has improved - days down from 110 to 70
- Offers a healthy dividend yield of 3.8%
- Company converts assets efficiently - asset turnover of 2.0x
CONS
- Stock is trading at 15.3x its book value
- Dividend payout exceeds earnings (104.1%) - may be unsustainable
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | 1842.00 | 36.54 | 441957.50 | 0.87 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| DIVISLAB | 9326.00 | 84.64 | 247576.00 | 0.32 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| TORNTPHARM | 4975.00 | 86.76 | 189233.01 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| ZYDUSLIFE | 1119.50 | 24.74 | 111670.55 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| CIPLA | 1365.00 | 32.72 | 110272.68 | 0.95 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| LAURUSLABS | 1970.35 | 97.37 | 106460.42 | 0.10 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| DRREDDY | 1161.00 | 30.07 | 96906.38 | 0.69 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| AUROPHARMA | 1675.45 | 25.97 | 96401.69 | 0.24 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| LUPIN | 2096.00 | 17.34 | 95842.92 | 0.86 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| MANKIND | 2277.00 | 46.04 | 94050.37 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| GLENMARK | 2416.90 | 37.94 | 68210.88 | 0.10 | 482.83 | 927.88 | 4018.48 | 31.35 | 20.35 | 20.03 |
| PGHL | 5410.15 | 25.16 | 8980.51 | 3.79 | 96.15 | 45.29 | 363.71 | 7.37 | 84.86 | 27.38 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 301 | 305 | 310 | 252 | 284 | 313 | 310 | 311 | 339 | 325 | 374 | 370 | 364 | |
| 256 | 216 | 208 | 185 | 236 | 199 | 186 | 230 | 248 | 205 | 263 | 235 | 270 | |
| Operating Profit | 45 | 89 | 102 | 67 | 48 | 114 | 123 | 81 | 90 | 120 | 110 | 136 | 93 |
| OPM % | 15.05% | 29.08% | 32.79% | 26.71% | 17.00% | 36.39% | 39.85% | 26.02% | 26.67% | 37.02% | 29.55% | 36.60% | 25.69% |
| 5 | 6 | 5 | 2 | -18 | 3 | 4 | 3 | 4 | 5 | 4 | 4 | -28 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 6 | 6 | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 |
| Profit before Tax | 44 | 88 | 100 | 63 | 23 | 111 | 122 | 79 | 89 | 119 | 109 | 133 | 129 |
| Tax % | 32.43% | 25.53% | 27.73% | 25.77% | 26.50% | 26.10% | 25.30% | 22.09% | 25.48% | 25.61% | 28.70% | 28.98% | 25.53% |
| Net Profit | 30 | 66 | 72 | 47 | 17 | 82 | 91 | 61 | 66 | 89 | 78 | 95 | 96 |
| 17.96 | 39.50 | 43.42 | 28.05 | 10.11 | 49.60 | 54.76 | 36.86 | 39.87 | 53.34 | 46.74 | 56.99 | 57.92 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|
| 934 | 1,408 | 1,433 | |
| 616 | 955 | 973 | |
| Operating Profit | 318 | 453 | 460 |
| OPM % | 34.08% | 32.17% | 32.09% |
| 10 | 21 | -15 | |
| Interest | 0 | 1 | 1 |
| Depreciation | 17 | 24 | 24 |
| Profit before Tax | 312 | 450 | 490 |
| Tax % | 24.78% | 27.33% | 27.19% |
| Net Profit | 234 | 327 | 357 |
| EPS | 141.21 | 196.93 | — |
| Dividend Payout % | 88.52% | 104.10% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 22%
- 5 Years:
- 0%
- 3 Years:
- 2%
- 1 Year:
- -15%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- Last Year:
- 62%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 17 | 17 |
| 515 | 503 | |
| 6 | 7 | |
| Trade Payables | 172 | 192 |
| 50 | 92 | |
| Total Liabilities | 759 | 811 |
| 112 | 100 | |
| Capital Work in Progress | 11 | 14 |
| 109 | 137 | |
| 145 | 164 | |
| Cash & Bank | 189 | 185 |
| 193 | 211 | |
| Total Assets | 759 | 811 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 169 | 338 | |
| Cash from Investing | 10 | 1 |
| Cash from Financing | -235 | -344 |
| -56 | -5 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-04 - Procter & Gamble Health Limited has informed the Exchange regarding 'This is in reference to our letter dated May 26, 2026, regarding re-appointment of Mr. S.Madhavan as Independent Director of the Company, for a period of five years, with effect fromNovember 15, 2026, subject to the approval of the shareholders of the Company. We are pleasedto inform you that the re-appointment of Mr. S. Madhavan as Independent Director of theCompany has been approved by the shareholders of the Company at its 59th Annual GeneralMeeting ( AGM ) held on September 3, 2026.'.
2026-09-04 - Procter & Gamble Health Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 03, 2026. Further, the company has informed the Exchange regarding voting results.
2026-09-03 - Procter & Gamble Health Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 03, 2026
2026-09-03 - Procter & Gamble Health Limited has informed the Exchange about Shareholders meeting
2026-08-12 - Procter & Gamble Health Limited has informed the Exchange about Shareholders meeting
2026-08-10 - Procter & Gamble Health Limited had intimated the 21-Aug-2026 as the record date. The Company has now informed the Exchange that the Record date has been revised to 27-Aug-2026 for the purpose of DI.
2026-08-06 - Procter & Gamble Health Limited has informed the Exchange regarding a press release dated August 06, 2026, titled "Press Release on the unaudited Financial Results for the quarter ended June 30, 2026".
2026-08-06 - Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the quarter ended June 30, 2026.
2026-07-15 - Procter & Gamble Health Limited has informed the Exchange regarding revision in date of Company s Annual General Meeting for the Financial Year 2025-26 and Record date for the purpose of AGM and Final Dividend
News
Recent coverage and analyst commentary for PGHL
Loading news…
AI Stock Analyst
Procter & Gamble Health Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account